Thomas Brida net worth and biography

Thomas Brida Biography and Net Worth

General Counsel of Invitae
Tom leads the legal and compliance team at Invitae. Tom has a broad-based legal background in the life science and diagnostic industries, having advised both public and private multinational companies on transactional​​ and corporate matters. Prior to joining Invitae, Tom served as associate general counsel at Bio-Rad Laboratories and associate in Orrick's corporate and technology group. Tom holds a B.A. from Stanford University and a law degree from U.C. Berkeley School of Law.

What is Thomas Brida's net worth?

The estimated net worth of Thomas Brida is at least $1.15 million as of August 16th, 2022. Mr. Brida owns 386,267 shares of Invitae stock worth more than $1,147,213 as of December 1st. This net worth approximation does not reflect any other assets that Mr. Brida may own. Additionally, Mr. Brida receives an annual salary of $425,000.00 as General Counsel at Invitae. Learn More about Thomas Brida's net worth.

How old is Thomas Brida?

Mr. Brida is currently 51 years old. There are 6 older executives and no younger executives at Invitae. The oldest executive at Invitae is Dr. Robert L. Nussbaum M.D., Chief Medical Officer, who is 72 years old. Learn More on Thomas Brida's age.

What is Thomas Brida's salary?

As the General Counsel of Invitae Co., Mr. Brida earns $425,000.00 per year. There are 2 executives that earn more than Mr. Brida. The highest earning executive at Invitae is Mr. Kenneth D. Knight, Pres, CEO & Director, who commands a salary of $1,000,000.00 per year. Learn More on Thomas Brida's salary.

How do I contact Thomas Brida?

The corporate mailing address for Mr. Brida and other Invitae executives is 1400 16th Street, SAN FRANCISCO CA, 94103. Invitae can also be reached via phone at (415) 374-7782 and via email at [email protected] Learn More on Thomas Brida's contact information.

Has Thomas Brida been buying or selling shares of Invitae?

Thomas Brida has not been actively trading shares of Invitae within the last three months. Most recently, Thomas Brida sold 7,048 shares of the business's stock in a transaction on Tuesday, August 16th. The shares were sold at an average price of $4.55, for a transaction totalling $32,068.40. Following the completion of the sale, the insider now directly owns 386,267 shares of the company's stock, valued at $1,757,514.85. Learn More on Thomas Brida's trading history.

Who are Invitae's active insiders?

Invitae's insider roster includes Thomas Brida (General Counsel), Sean George (CEO), Shelly Guyer (CFO), Robert Nussbaum (Insider), Katherine Stueland (Insider), and Robert Werner (CAO). Learn More on Invitae's active insiders.

Are insiders buying or selling shares of Invitae?

During the last year, insiders at the medical research company sold shares 15 times. They sold a total of 188,179 shares worth more than $954,194.71. The most recent insider tranaction occured on August, 25th when CAO Robert F Werner sold 1,350 shares worth more than $4,657.50. Insiders at Invitae own 1.1 % of the company. Learn More about insider trades at Invitae.

Information on this page was last updated on 8/25/2022.

Thomas Brida Insider Trading History at Invitae

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/16/2022Sell7,048$4.55$32,068.40386,267View SEC Filing Icon  
5/17/2022Sell6,098$3.81$23,233.38393,315View SEC Filing Icon  
3/14/2022Sell17,987$6.69$120,333.03View SEC Filing Icon  
8/16/2021Sell14,438$25.42$367,013.96View SEC Filing Icon  
3/12/2021Sell16,051$42.90$688,587.90View SEC Filing Icon  
11/17/2020Sell5,000$46.01$230,050.00View SEC Filing Icon  
9/10/2020Sell633$33.87$21,439.71View SEC Filing Icon  
8/19/2020Sell12,416$32.10$398,553.60View SEC Filing Icon  
5/20/2020Sell2,060$16.70$34,402.00View SEC Filing Icon  
3/16/2020Sell9,226$11.79$108,774.54175,094View SEC Filing Icon  
8/19/2019Sell13,663$25.29$345,537.27View SEC Filing Icon  
5/20/2019Sell2,146$18.21$39,078.66View SEC Filing Icon  
5/15/2018Sell1,979$6.96$13,773.84View SEC Filing Icon  
2/16/2017Sell766$9.69$7,422.5424,720View SEC Filing Icon  
2/15/2017Sell794$9.54$7,574.7626,280View SEC Filing Icon  
See Full Table

Thomas Brida Buying and Selling Activity at Invitae

This chart shows Thomas Brida's buying and selling at Invitae by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Invitae Company Overview

Invitae logo
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
Read More

Today's Range

Now: $3.00
Low: $2.88
High: $3.10

50 Day Range

MA: $2.56
Low: $2.03
High: $3.61

2 Week Range

Now: $3.00
Low: $1.83
High: $18.44

Volume

174,938 shs

Average Volume

9,376,406 shs

Market Capitalization

$728.70 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.59
Without Graphite, There Would Be ZERO EV Batteries!
Investors constantly hear that lithium is the key to powering the transition to green energy. Truth is, today's EV batteries contain more graphite in volume than any other essential ingredients.
See This Special Report to Get the Full Story